IXABEPILONE Side Effects

7006515-4 | Cellulitis, Erythema, Oedema Peripheral, Pain
on Sep 21, 2010 Female patient from UNITED STATES , 54 years of age, weighting 255.7 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ixabepilone (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), erythema, oedema peripheral, pain (What is pain?). Ixabepilone dosage: 32mg/m2 Iv Every 3 Wks. During the same period patient was treated with VORINOSTAT (300mg Po Dailyx14 D/cycl) (View Vorinostat Review and Vorinostat Label ), ALFALFA SUPP (View Alfalfa Supp Review and Alfalfa Supp Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), BENAZEPRIL HYDROCHLORIDE (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), LASIX (View Lasix Review and Lasix Label ), KLOR CON (View Klor-con Review and Klor-con Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6983399-1 | Intestinal Perforation
Patient was taking Ixabepilone (View Usage). Patient had the following side effects: intestinal perforation on Sep 13, 2010 from UNITED STATES Additional patient health information: Female patient , 78 years of age, was diagnosed with endometrial cancer and. Ixabepilone dosage: Interrupted On 23dec2009 After 2 Cycles At 65mg + Restarted On 21jan10:55mg For 2 Cycles.. During the same period patient was treated with COLESTID (View Colestid Review and Colestid Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TENORMIN (View Tenormin Review and Tenormin Label ), FLONASE (2 Df-2 Spray) (View Flonase Review and Flonase Label ), SENOKOT (1 Df-1-2 Tabs) (View Senokot Review and Senokot Label ), MIRALAX (1 Df-1 Pkt 17gm/pkt) (View Miralax Review and Miralax Label ), K DUR (View K-dur Review and K-dur Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

6974660-5 | Neutrophil Count Decreased
Adverse event was reported on Sep 09, 2010 by a Female patient taking Ixabepilone (View Usage) (Dosage: 32mg/m2 Q 3wks, Iv) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , weighting 210.8 lb, After Ixabepilone was administered, patient had the following side effects: neutrophil count decreased. During the same period patient was treated with VORINOSTAT (300mg Daily X14d/28d Po) (View Vorinostat Review and Vorinostat Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CA+ (View Ca+ Review and Ca+ Label ), COZAAR (View Cozaar Review and Cozaar Label ), IRON (View Iron Review and Iron Label ), JANUVIA (View Januvia Review and Januvia Label ), LYRICA (View Lyrica Review and Lyrica Label ), METAMUCIL 2 (View Metamucil-2 Review and Metamucil-2 Label ).

6966768-5 | Pericardial Effusion
on Aug 27, 2010 Female patient from UNITED STATES , 50 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ixabepilone (View Usage). Patient experienced the following unwanted or unexpected effects: pericardial effusion. Ixabepilone dosage: . During the same period patient was treated with HYDROXYCHLOROQUINE (View Hydroxychloroquine Review and Hydroxychloroquine Label ).


6964840-7 | Musculoskeletal Chest Pain
on Aug 26, 2010 Female patient from UNITED STATES , 54 years of age, weighting 275.6 lb, was diagnosed with breast cancer (What is breast cancer?), swelling and was treated with Ixabepilone (View Usage). Patient had the following side effects: musculoskeletal chest pain. Ixabepilone dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), TRASTUZUMAB (View Trastuzumab Review and Trastuzumab Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LASIX (Daily Prn) (View Lasix Review and Lasix Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), OXYCODONE (1 Df=10/325 Unit Nos Q6hrs) (View Oxycodone Review and Oxycodone Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ). Patient was hospitalized.

6958063-5 | Constipation, Fatigue, Pain
Patient was taking Ixabepilone (View Usage). After Ixabepilone was administered, patient had the following side effects: constipation (What is constipation?), fatigue, pain (What is pain?) on Aug 26, 2010 from UNITED STATES Additional patient health information: Female patient , 52 years of age, weighting 149.9 lb, was diagnosed with breast cancer (What is breast cancer?), pain (What is pain?), nausea (What is nausea?) and. Ixabepilone dosage: 20 Mg/m2; C1d8. During the same period patient was treated with CARBOPLATIN (1df- 2.5 Auc C1d8) (View Carboplatin Review and Carboplatin Label ), FLEXERIL (Tab; Prn) (View Flexeril Review and Flexeril Label ), MORPHINE (Tab; Prn) (View Morphine Review and Morphine Label ), MS CONTIN (Tab; Total= 45mg Q12 H) (View Ms Contin Review and Ms Contin Label ), PHENERGAN (View Phenergan Review and Phenergan Label ), REGLAN (Tab; Q4-6h Prn) (View Reglan Review and Reglan Label ), SENOKOT (View Senokot Review and Senokot Label ). Patient was hospitalized.

6957013-5 | Dehydration
Adverse event was reported on Aug 27, 2010 by a Female patient taking Ixabepilone (View Usage) (Dosage: 16mg/m2 On Days 2, 9 +16, Last Given On 8/10/10) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , weighting 126.3 lb, Patient experienced the following unwanted or unexpected effects: dehydration. During the same period patient was treated with VORINOSTAT (Po Daily On Days 1-7+15, Last Taken On 8/14/10) (View Vorinostat Review and Vorinostat Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), HALCION (View Halcion Review and Halcion Label ), VICODIN (View Vicodin Review and Vicodin Label ). Patient was hospitalized.

6942344-5 | Anaemia, Electrolyte Imbalance, Neuropathy Peripheral, Urinary Tract Infection
on Aug 23, 2010 Female patient from UNITED STATES , 67 years of age, weighting 134.5 lb, was diagnosed with breast cancer metastatic, tachycardia, hypercholesterolaemia, insomnia, depression (What is depression?), neuralgia, dizziness (What is dizziness?), gastrooesophageal reflux disease and was treated with Ixabepilone (View Usage). Patient had the following side effects: anaemia, electrolyte imbalance, neuropathy peripheral, urinary tract infection (What is urinary tract infection?). Ixabepilone dosage: Days 1,8 + 15; Interrupted On 27jul09; Stopped On 05aug09. During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), ZETIA (View Zetia Review and Zetia Label ), AMBIEN CR (Hs) (View Ambien Cr Review and Ambien Cr Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), NARCOTIC NOS (1 Df= 1 Tabs(10/325)) (View Narcotic Nos Review and Narcotic Nos Label ), MECLIZINE (View Meclizine Review and Meclizine Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

6937771-6 | Asthenia, Decreased Appetite, Diarrhoea, Dry Mouth, Dysgeusia, Feeling Cold, Fluid Intake Reduced, Hypophagia, Pyrexia
on Aug 23, 2010 Female patient from UNITED STATES , weighting 126.3 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ixabepilone (View Usage). After Ixabepilone was administered, patient had the following side effects: asthenia, decreased appetite, diarrhoea, dry mouth, dysgeusia, feeling cold, fluid intake reduced, hypophagia, pyrexia. Ixabepilone dosage: 16mg/m2 On Days 2,9 + 16. During the same period patient was treated with VORINOSTAT (Po Daily On Days 1-7 + 15) (View Vorinostat Review and Vorinostat Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), HALCION (View Halcion Review and Halcion Label ), VICODIN (View Vicodin Review and Vicodin Label ).

6931945-6 | Anal Abscess, Malignant Neoplasm Progression, Neutropenia
Patient was taking Ixabepilone (View Usage). Patient experienced the following unwanted or unexpected effects: anal abscess, malignant neoplasm progression, neutropenia on Aug 13, 2010 from KOREA, REPUBLIC OF Additional patient health information: Male patient , 58 years of age, was diagnosed with gastric cancer and. Ixabepilone dosage: 73mg:10feb2010 50mg: 10mar2010-cont. During the same period patient was treated with MEGESTROL (17feb2010-17feb2010 24feb2010-conti) (View Megestrol Review and Megestrol Label ). Patient was hospitalized.

6930142-8 | Chest Pain
Adverse event was reported on Aug 12, 2010 by a Female patient taking Ixabepilone (View Usage) (Dosage: Interrupted On 26feb2010) was diagnosed with breast cancer (What is breast cancer?), swelling and. Location: UNITED STATES , 54 years of age, weighting 275.6 lb, Patient had the following side effects: chest pain (What is chest pain?). During the same period patient was treated with CARBOPLATIN (Interrupted On 26feb2010) (View Carboplatin Review and Carboplatin Label ), TRASTUZUMAB (Interrupted On 14jul2010) (View Trastuzumab Review and Trastuzumab Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LASIX (Daily Prn) (View Lasix Review and Lasix Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), OXYCODONE (1 Df=10/325 Unit Nos Q6hrs) (View Oxycodone Review and Oxycodone Label ), PAROXETINE (View Paroxetine Review and Paroxetine Label ). Patient was hospitalized.

6882588-4 | Cholecystitis
on Jul 21, 2010 Female patient from UNITED STATES , 57 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ixabepilone (View Usage). After Ixabepilone was administered, patient had the following side effects: cholecystitis. Ixabepilone dosage: Last Dose On:4jun2010; Cycle 7 Day28:17jun2010 On Day 1,8 +15. During the same period patient was treated with BEVACIZUMAB (Last Dose On:4jun2010; Cycle 7 Day28:17jun2010 On Day 1 +15) (View Bevacizumab Review and Bevacizumab Label ).

6869443-0 | Cough, Pyrexia
on Jul 22, 2010 Male patient from UNITED STATES , weighting 200.0 lb, was diagnosed with oesophageal cancer metastatic and was treated with Ixabepilone (View Usage). Patient experienced the following unwanted or unexpected effects: cough, pyrexia. Ixabepilone dosage: 42 Mg; Day 1,8 And 15 Of Each Cycle. During the same period patient was treated with SUNITINIB MALATE (37.5 Mg; Every Day Starting On Cycle 1 Day 8) (View Sunitinib Malate Review and Sunitinib Malate Label ), VIT C (View Vit C Review and Vit C Label ), MV (View Mv Review and Mv Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), MOTRIN (View Motrin Review and Motrin Label ), COMPAZINE (View Compazine Review and Compazine Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

6869437-5 | Bacterial Infection, Blood Culture Positive, Chills, Device Related Infection, Feeling Abnormal, Pyrexia
Patient was taking Ixabepilone (View Usage). Patient had the following side effects: bacterial infection (What is bacterial infection?), blood culture positive, chills, device related infection, feeling abnormal, pyrexia on Jul 22, 2010 from UNITED STATES Additional patient health information: Female patient , 54 years of age, weighting 252.4 lb, was diagnosed with breast cancer (What is breast cancer?) and. Ixabepilone dosage: 32mg/m2 Every 3 Weeks/21 D Iv. During the same period patient was treated with VORINOSTAT (300mg Qd X 2wks/21 D Po) (View Vorinostat Review and Vorinostat Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), IRON SUP (View Iron Sup Review and Iron Sup Label ), LASIX (View Lasix Review and Lasix Label ), POT SUP (View Pot Sup Review and Pot Sup Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ZOCOR (View Zocor Review and Zocor Label ), ULTRAM (View Ultram Review and Ultram Label ). Patient was hospitalized.

6869116-4 | Atrial Fibrillation, Chest Discomfort, Electrocardiogram Qt Prolonged, Tachycardia
Adverse event was reported on Jul 22, 2010 by a Female patient taking Ixabepilone (View Usage) (Dosage: 40mg/m2 Iv Q3wk) was diagnosed with adenoid cystic carcinoma and. Location: UNITED STATES , 60 years of age, weighting 154.0 lb, After Ixabepilone was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), chest discomfort, electrocardiogram qt prolonged, tachycardia. During the same period patient was treated with DASATINIB (100mg Po Daily) (View Dasatinib Review and Dasatinib Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), ACCUPRIL (View Accupril Review and Accupril Label ), ACTOPLUS MET (View Actoplus Met Review and Actoplus Met Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6821978-2 | Cancer Pain, Condition Aggravated, Fatigue, Malignant Neoplasm Progression, Metastatic Carcinoma Of The Bladder
on Jul 07, 2010 Female patient from UNITED STATES , weighting 120.0 lb, was diagnosed with bladder cancer (What is bladder cancer?) and was treated with Ixabepilone (View Usage). Patient experienced the following unwanted or unexpected effects: cancer pain, condition aggravated, fatigue, malignant neoplasm progression, metastatic carcinoma of the bladder. Ixabepilone dosage: 15mg/m2 Day 1,8 + 15 Iv. During the same period patient was treated with LAPATINIB (1000mg Daily Po) (View Lapatinib Review and Lapatinib Label ).

6775453-4 | Lymphocele, Pulmonary Embolism
on Jun 15, 2010 Female patient from FRANCE , 49 years of age, weighting 158.7 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ixabepilone (View Usage). Patient had the following side effects: lymphocele, pulmonary embolism (What is pulmonary embolism?). Ixabepilone dosage: Total Given 136 Mg. During the same period patient was treated with CYCLOPHOSPHAMIDE (Total Given 2580 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUOROURACIL (Total Given 2580 Mg) (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (Total Given 510 Mg) (View Epirubicin Review and Epirubicin Label ). Patient was hospitalized.

6763855-1 | Anaemia, Coma, Diarrhoea, Dyspnoea, Febrile Neutropenia, Hypotension, Multi-organ Failure, Stomatitis, Thrombocytopenia
Patient was taking Ixabepilone (View Usage). After Ixabepilone was administered, patient had the following side effects: anaemia, coma, diarrhoea, dyspnoea, febrile neutropenia, hypotension, multi-organ failure, stomatitis, thrombocytopenia on Jun 08, 2010 from ITALY Additional patient health information: Female patient , 54 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Ixabepilone dosage: . Patient was hospitalized.

6759548-7 | Blood Creatinine Increased
Adverse event was reported on Jun 03, 2010 by a Male patient taking Ixabepilone (View Usage) (Dosage: 47mg:02nov-02nov09;received 3rd Cycle On 25nov09.) was diagnosed with non-small cell lung cancer and. Location: KOREA, REPUBLIC OF , 69 years of age, Patient experienced the following unwanted or unexpected effects: blood creatinine increased. During the same period patient was treated with CARBOPLATIN (419 Mg:02nov09;received 3rd Cycle On 25nov09.) (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6756723-2 | Anaemia, Coma, Diarrhoea, Dyspnoea, Febrile Neutropenia, Hypotension, Stomatitis, Thrombocytopenia
on May 31, 2010 Female patient from ITALY , 54 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ixabepilone (View Usage). Patient had the following side effects: anaemia, coma, diarrhoea, dyspnoea, febrile neutropenia, hypotension, stomatitis, thrombocytopenia. Ixabepilone dosage: . Patient was hospitalized.

6695482-9 | Infection
on Apr 21, 2010 Female patient from UNITED STATES , 49 years of age, weighting 211.6 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ixabepilone (View Usage). After Ixabepilone was administered, patient had the following side effects: infection (What is infection?). Ixabepilone dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), TRASTUZUMAB (View Trastuzumab Review and Trastuzumab Label ), CYCLOBENZAPRINE HCL (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), OXYCODONE HCL (1df-5/325mg) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), TRAZODONE HCL (1 Df- 50-75 Mg) (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

6684466-2 | Infection
Patient was taking Ixabepilone (View Usage). Patient experienced the following unwanted or unexpected effects: infection (What is infection?) on Apr 14, 2010 from UNITED STATES Additional patient health information: Female patient , 49 years of age, weighting 211.6 lb, was diagnosed with breast cancer (What is breast cancer?) and. Ixabepilone dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), TRASTUZUMAB (View Trastuzumab Review and Trastuzumab Label ), CYCLOBENZAPRINE HCL (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), OXYCODONE HCL (1df-5/325mg) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), TRAZODONE HCL (1 Df- 50-75 Mg) (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

6668088-5 | Abscess
Adverse event was reported on Apr 02, 2010 by a Female patient taking Ixabepilone (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 49 years of age, weighting 211.6 lb, Patient had the following side effects: abscess (What is abscess?). During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), TRASTUZUMAB (View Trastuzumab Review and Trastuzumab Label ), CYCLOBENZAPRINE HCL (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ), OXYCODONE HCL (1df-5/325mg) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), TRAZODONE HCL (1 Df- 50-75 Mg) (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

6666350-3 | Dizziness
on Mar 26, 2010 Male patient from KOREA, REPUBLIC OF , 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Ixabepilone (View Usage). After Ixabepilone was administered, patient had the following side effects: dizziness (What is dizziness?). Ixabepilone dosage: Strength:32mg/m2;received 6 Cycles Until 07jan2010;initial Dose:22sep09.. During the same period patient was treated with CARBOPLATIN (Auc 6 ;received 6 Cycles Until 07jan2010;initial Dose:22sep09.) (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6659930-2 | Abdominal Pain, Blood Glucose Increased, Hypertension, Lymphopenia, Upper Respiratory Tract Infection
on Mar 23, 2010 Female patient from UNITED STATES , child 8 years of age, weighting 61.73 lb, was diagnosed with neuroblastoma (What is neuroblastoma?) and was treated with Ixabepilone (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood glucose increased, hypertension, lymphopenia, upper respiratory tract infection. Ixabepilone dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6656927-3 | Abdominal Pain, Arthralgia, Dehydration, Fatigue, Myalgia, Neutrophil Count Increased, Rhinitis Allergic
Patient was taking Ixabepilone (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), arthralgia, dehydration, fatigue, myalgia, neutrophil count increased, rhinitis allergic on Mar 25, 2010 from UNITED STATES Additional patient health information: Male patient , 24 years of age, weighting 174.2 lb, was diagnosed with synovial sarcoma and. Ixabepilone dosage: 8mg/m2 Over 1hr On Days 1-5 21 Day Cycle. Patient was hospitalized.

6654758-1 | Pancreatitis, Pneumothorax
Adverse event was reported on Mar 23, 2010 by a Female patient taking Ixabepilone (View Usage) (Dosage: ) was diagnosed with nephroblastoma and. Location: UNITED STATES , child 10 years of age, weighting 52.91 lb, After Ixabepilone was administered, patient had the following side effects: pancreatitis, pneumothorax. During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), MIRALAX (View Miralax Review and Miralax Label ), ATIVAN (View Ativan Review and Ativan Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), HEPARIN (View Heparin Review and Heparin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ). Patient was hospitalized.

6653176-X | Constipation, Fatigue, Pain
on Mar 22, 2010 Female patient from UNITED STATES , 52 years of age, weighting 149.9 lb, was diagnosed with breast cancer (What is breast cancer?), pain (What is pain?), nausea (What is nausea?) and was treated with Ixabepilone (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), fatigue, pain (What is pain?). Ixabepilone dosage: 20 Mg/m2; C1d8. During the same period patient was treated with CARBOPLATIN (1df- 2.5 Auc) (View Carboplatin Review and Carboplatin Label ), FLEXERIL (Tab; Prn) (View Flexeril Review and Flexeril Label ), MORPHINE (Tab; Prn) (View Morphine Review and Morphine Label ), MS CONTIN (Tab; Total= 45mg Q12 H) (View Ms Contin Review and Ms Contin Label ), PHENERGAN HCL (View Phenergan Hcl Review and Phenergan Hcl Label ), REGLAN (Tab; Q4-6h Prn) (View Reglan Review and Reglan Label ), SENOKOT (View Senokot Review and Senokot Label ). Patient was hospitalized.

6647699-7 | Malignant Neoplasm Progression, Neuropathy Peripheral
on Mar 12, 2010 Female patient from SPAIN , 48 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ixabepilone (View Usage). Patient had the following side effects: malignant neoplasm progression, neuropathy peripheral. Ixabepilone dosage: Dose Reduced To 30mg/m2.. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), THIOTEPA (View Thiotepa Review and Thiotepa Label ), NAVELBINE (View Navelbine Review and Navelbine Label ). Patient was hospitalized.

6643668-1 | Abdominal Abscess, Blood Culture Positive, Diverticulitis, Hiccups, Hypotension, Intestinal Perforation, Neutropenia, Nosocomial Infection, Peritonitis
Patient was taking Ixabepilone (View Usage). After Ixabepilone was administered, patient had the following side effects: abdominal abscess, blood culture positive, diverticulitis, hiccups, hypotension, intestinal perforation, neutropenia, nosocomial infection, peritonitis on Mar 18, 2010 from UNITED STATES Additional patient health information: Male patient , 63 years of age, weighting 180.8 lb, was diagnosed with neoplasm, pancreatic carcinoma metastatic and. Ixabepilone dosage: Dose Frequency: Day 1,8+15. Cycle 3 Day 1 Started On 19jan2010. Cycle 1 Day 1 On 23nov2009-unk. During the same period patient was treated with SUNITINIB MALATE (Dose Frequency: Starts On Day 8. Cycle 3 Day 1 Started On 19jan2010.) (View Sunitinib Malate Review and Sunitinib Malate Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), CELEBREX (View Celebrex Review and Celebrex Label ), MULTIPLE VITAMINS (View Multiple Vitamins Review and Multiple Vitamins Label ), CADUET (View Caduet Review and Caduet Label ), VICODIN (View Vicodin Review and Vicodin Label ), OSTEO BI FLEX (View Osteo Bi-flex Review and Osteo Bi-flex Label ). Patient was hospitalized.

6638148-3 | Small Intestinal Obstruction
Adverse event was reported on Mar 15, 2010 by a Male patient taking Ixabepilone (View Usage) (Dosage: 22 Mg) was diagnosed with colorectal cancer metastatic and. Location: UNITED STATES , weighting 148.5 lb, Patient experienced the following unwanted or unexpected effects: small intestinal obstruction. During the same period patient was treated with SUNITINIB 37.5 MG/DOSE (View Sunitinib 37.5 Mg/dose Review and Sunitinib 37.5 Mg/dose Label ). Patient was hospitalized.

6635938-8 | Anal Abscess, Neutropenia
on Mar 10, 2010 Male patient from KOREA, REPUBLIC OF , 58 years of age, was diagnosed with gastric cancer and was treated with Ixabepilone (View Usage). Patient had the following side effects: anal abscess, neutropenia. Ixabepilone dosage: 73mg:10feb2010 50mg: 10mar2010-cont. During the same period patient was treated with MEGESTROL (17feb2010-17feb2010 24feb2010-conti) (View Megestrol Review and Megestrol Label ). Patient was hospitalized.

6635699-2 | Colon Cancer Metastatic, Intestinal Perforation, Peritonitis, Small Intestinal Obstruction
on Mar 12, 2010 Male patient from UNITED STATES , 59 years of age, weighting 249.0 lb, was diagnosed with colorectal cancer metastatic and was treated with Ixabepilone (View Usage). After Ixabepilone was administered, patient had the following side effects: colon cancer metastatic, intestinal perforation, peritonitis, small intestinal obstruction. Ixabepilone dosage: 22 Mg. During the same period patient was treated with SUNITINIB 37.5 MG/DOSE (37.5 Oral) (View Sunitinib 37.5 Mg/dose Review and Sunitinib 37.5 Mg/dose Label ). Patient was hospitalized.

6619329-1 | Anal Abscess, Neutropenia
Patient was taking Ixabepilone (View Usage). Patient experienced the following unwanted or unexpected effects: anal abscess, neutropenia on Mar 03, 2010 from KOREA, REPUBLIC OF Additional patient health information: Male patient , 58 years of age, was diagnosed with gastric cancer and. Ixabepilone dosage: . During the same period patient was treated with MEGESTROL (17feb2010-17feb2010 24feb2010-conti) (View Megestrol Review and Megestrol Label ). Patient was hospitalized.

6619326-6 | Dehydration, Musculoskeletal Chest Pain, Vomiting
Adverse event was reported on Mar 04, 2010 by a Female patient taking Ixabepilone (View Usage) (Dosage: ) was diagnosed with neoplasm malignant and. Location: UNITED STATES , 59 years of age, Patient had the following side effects: dehydration, musculoskeletal chest pain, vomiting. During the same period patient was treated with LOPRESSOR (View Lopressor Review and Lopressor Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ). Patient was hospitalized.

6615118-2 | Intestinal Perforation
on Mar 02, 2010 Female patient from UNITED STATES , 78 years of age, was diagnosed with endometrial cancer and was treated with Ixabepilone (View Usage). After Ixabepilone was administered, patient had the following side effects: intestinal perforation. Ixabepilone dosage: Interrupted On 23dec2009 After 2 Cycles At 65mg + Restarted On 21jan10:55mg For 2 Cycles.. During the same period patient was treated with COLESTID (View Colestid Review and Colestid Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TENORMIN (View Tenormin Review and Tenormin Label ), FLONASE (2 Df-2 Spray) (View Flonase Review and Flonase Label ), SENOKOT (1 Df-1-2 Tabs) (View Senokot Review and Senokot Label ), MIRALAX (1 Df-1 Pkt 17gm/pkt) (View Miralax Review and Miralax Label ), K DUR (View K-dur Review and K-dur Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

6615117-0 | Dehydration, Musculoskeletal Chest Pain, Vomiting
on Mar 02, 2010 Female patient from UNITED STATES , 59 years of age, was diagnosed with neoplasm malignant and was treated with Ixabepilone (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, musculoskeletal chest pain, vomiting. Ixabepilone dosage: Interrupted On 24sep07. During the same period patient was treated with LOPRESSOR (View Lopressor Review and Lopressor Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ). Patient was hospitalized.

6614352-5 | Fatigue, Pneumonia, Walking Aid User
Patient was taking Ixabepilone (View Usage). Patient had the following side effects: fatigue, pneumonia (What is pneumonia?), walking aid user on Mar 03, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 181.5 lb, . Ixabepilone dosage: 32 Mg Day 1, 8, + 15. During the same period patient was treated with SUNITINIB MALATE (37.5 Mg Daily Starting On Day 8) (View Sunitinib Malate Review and Sunitinib Malate Label ), MEGESTROL (View Megestrol Review and Megestrol Label ), PANCRELIPASE (View Pancrelipase Review and Pancrelipase Label ), NEXIUM (View Nexium Review and Nexium Label ), PROPRANOLOL HYDROCHLORIDE (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), ZINC SULFATE (View Zinc Sulfate Review and Zinc Sulfate Label ), VIT C (View Vit C Review and Vit C Label ). Patient was hospitalized.

6610985-0 | Aplasia, Multi-organ Failure, Renal Failure, Respiratory Distress, Septic Shock
Adverse event was reported on Feb 26, 2010 by a Female patient taking Ixabepilone (View Usage) (Dosage: 70 Mg Total) was diagnosed with breast cancer (What is breast cancer?) and. Location: FRANCE , 54 years of age, weighting 136.7 lb, After Ixabepilone was administered, patient had the following side effects: aplasia, multi-organ failure, renal failure, respiratory distress, septic shock. During the same period patient was treated with CYCLOPHOSPHAMIDE (2610 Mg Total) (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUOROURACIL (2610 Mg Total) (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (522 Mg Total) (View Epirubicin Review and Epirubicin Label ), NEXIUM (View Nexium Review and Nexium Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), VOGALENE (View Vogalene Review and Vogalene Label ), ZOPHREN (View Zophren Review and Zophren Label ). Patient was hospitalized.

6607310-8 | Intestinal Perforation, Neutropenia
on Feb 24, 2010 Male patient from UNITED STATES , 63 years of age, weighting 180.8 lb, was diagnosed with neoplasm, pancreatic carcinoma metastatic and was treated with Ixabepilone (View Usage). Patient experienced the following unwanted or unexpected effects: intestinal perforation, neutropenia. Ixabepilone dosage: Dose Frequency: Day 1,8+15. Cycle 3 Day 1 Started On 19jan2010.. During the same period patient was treated with SUNITINIB MALATE (Dose Frequency: Starts On Day 8. Cycle 3 Day 1 Started On 19jan2010.) (View Sunitinib Malate Review and Sunitinib Malate Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), CELEBREX (View Celebrex Review and Celebrex Label ), MULTIPLE VITAMINS (View Multiple Vitamins Review and Multiple Vitamins Label ), CADUET (View Caduet Review and Caduet Label ), VICODIN (View Vicodin Review and Vicodin Label ), OSTEO BI FLEX (View Osteo Bi-flex Review and Osteo Bi-flex Label ). Patient was hospitalized.

6598056-3 | Intestinal Perforation
on Feb 18, 2010 Female patient from UNITED STATES , 78 years of age, was diagnosed with endometrial cancer and was treated with Ixabepilone (View Usage). Patient had the following side effects: intestinal perforation. Ixabepilone dosage: Interrupted On 23dec2009 After 2 Cycles At 65mg + Restarted On 21jan10:55mg For 2 Cycles.. Patient was hospitalized.

6598051-4 | Aplasia, Multi-organ Failure, Renal Failure, Respiratory Distress, Septic Shock
Patient was taking Ixabepilone (View Usage). After Ixabepilone was administered, patient had the following side effects: aplasia, multi-organ failure, renal failure, respiratory distress, septic shock on Feb 17, 2010 from FRANCE Additional patient health information: Female patient , 54 years of age, weighting 136.7 lb, was diagnosed with breast cancer (What is breast cancer?) and. Ixabepilone dosage: 70 Mg Total. During the same period patient was treated with CYCLOPHOSPHAMIDE (2610 Mg Total) (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUOROURACIL (2610 Mg Total) (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (522 Mg Total) (View Epirubicin Review and Epirubicin Label ), NEXIUM (View Nexium Review and Nexium Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), VOGALENE (View Vogalene Review and Vogalene Label ), ZOPHREN (View Zophren Review and Zophren Label ). Patient was hospitalized.

6590153-1 | Urinary Retention, Urinary Tract Infection
Adverse event was reported on Feb 17, 2010 by a Female patient taking Ixabepilone (View Usage) (Dosage: Route :ev) was diagnosed with osteoporosis (What is osteoporosis?), deep vein thrombosis (What is deep vein thrombosis?) and. Location: ITALY , 48 years of age, Patient experienced the following unwanted or unexpected effects: urinary retention, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), SELEDIE (View Seledie Review and Seledie Label ). Patient was hospitalized.

6580800-2 | Decreased Appetite, Diarrhoea, Febrile Bone Marrow Aplasia, Mucosal Inflammation, Thrombocytopenia, Weight Decreased
on Feb 09, 2010 Female patient from FRANCE , 68 years of age, weighting 183.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ixabepilone (View Usage). Patient had the following side effects: decreased appetite, diarrhoea, febrile bone marrow aplasia, mucosal inflammation, thrombocytopenia, weight decreased. Ixabepilone dosage: Cummulative Dose: 75.6 Mg. During the same period patient was treated with CYCLOPHOSPHAMIDE (Cummulative Dose: 2850 Mg.) (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUOROURACIL (Cummulative Dose: 2850 Mg.) (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (Cummulative Dose: 570 Mg.) (View Epirubicin Review and Epirubicin Label ).

6577955-2 | Febrile Bone Marrow Aplasia, Multi-organ Failure, Septic Shock
on Feb 08, 2010 Female patient from FRANCE , 63 years of age, weighting 196.2 lb, was diagnosed with breast cancer (What is breast cancer?), hypolipidaemia and was treated with Ixabepilone (View Usage). After Ixabepilone was administered, patient had the following side effects: febrile bone marrow aplasia, multi-organ failure, septic shock. Ixabepilone dosage: Cumulative Dose 78mg. During the same period patient was treated with CYCLOPHOSPHAMIDE (13mar08 - 24apr08, Cumulative Dose 2790mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), 5FU (13mar08-24apr08, Cumulative Dose 2970mg) (View 5fu Review and 5fu Label ), EPIRUBICIN (13mar08 - 24apr08, Cumulative Dose 594mg) (View Epirubicin Review and Epirubicin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), LYSINE ACETYLSALICYLATE (View Lysine Acetylsalicylate Review and Lysine Acetylsalicylate Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), SOTALOL (View Sotalol Review and Sotalol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6576231-1 | Cardiac Failure
Patient was taking Ixabepilone (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure on Feb 05, 2010 from GERMANY Additional patient health information: Female patient , 69 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Ixabepilone dosage: Second Dose Given On 02-mar-2009. Patient was hospitalized.

6576230-X | Arteriosclerosis Coronary Artery, Dyspnoea, Hypotension, Myocardial Ischaemia
Adverse event was reported on Feb 08, 2010 by a Female patient taking Ixabepilone (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?), cerebrovascular accident, hypertension and. Location: GREECE , 68 years of age, weighting 198.4 lb, Patient had the following side effects: arteriosclerosis coronary artery, dyspnoea, hypotension, myocardial ischaemia. During the same period patient was treated with ZOFRAN (View Zofran Review and Zofran Label ), ZANTAC (View Zantac Review and Zantac Label ), FENISTIL (View Fenistil Review and Fenistil Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), PLAVIX (View Plavix Review and Plavix Label ), PENTOPRIL (Pentopril-enalapril 20 Mg + 12.5 Mg.) (View Pentopril Review and Pentopril Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6572906-9 | Intestinal Perforation, Neutropenia
on Feb 03, 2010 Male patient from UNITED STATES , 63 years of age, was diagnosed with neoplasm and was treated with Ixabepilone (View Usage). After Ixabepilone was administered, patient had the following side effects: intestinal perforation, neutropenia. Ixabepilone dosage: Dose Frequency: Day 1,8+15. Cycle 3 Day 1 Started On 19jan2010.. During the same period patient was treated with SUNITINIB MALATE (Dose Frequency: Starts On Day 8. Cycle 3 Day 1 Started On 19jan2010.) (View Sunitinib Malate Review and Sunitinib Malate Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), CELEBREX (View Celebrex Review and Celebrex Label ), MULTIPLE VITAMINS (View Multiple Vitamins Review and Multiple Vitamins Label ), CADUET (View Caduet Review and Caduet Label ), VICODIN (View Vicodin Review and Vicodin Label ), OSTEO BI FLEX (View Osteo Bi-flex Review and Osteo Bi-flex Label ), CREON (View Creon Review and Creon Label ). Patient was hospitalized.

6572905-7 | Cardiac Failure
on Jan 27, 2010 Female patient from GERMANY , 69 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Ixabepilone (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure. Ixabepilone dosage: Second Dose Given On 02-mar-2009. Patient was hospitalized.

6572902-1 | Lymphocele, Pulmonary Embolism
Patient was taking Ixabepilone (View Usage). Patient had the following side effects: lymphocele, pulmonary embolism (What is pulmonary embolism?) on Feb 03, 2010 from FRANCE Additional patient health information: Female patient , 49 years of age, weighting 158.7 lb, was diagnosed with breast cancer (What is breast cancer?) and. Ixabepilone dosage: Total Given 136 Mg. During the same period patient was treated with CYCLOPHOSPHAMIDE (Total Given 2580 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUOROURACIL (Total Given 2580 Mg) (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (Total Given 510 Mg) (View Epirubicin Review and Epirubicin Label ). Patient was hospitalized.